Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes.
CONTEXT: An increase in bone fractures has been observed in women taking thiazolidinediones. OBJECTIVE: The objective of the study was to examine whether changes in circulating bone biomarkers provide insight into the underlying mechanisms responsible for the increase in bone fractures in female pa...
Main Authors: | Zinman, B, Haffner, S, Herman, W, Holman, R, Lachin, J, Kravitz, BG, Paul, G, Jones, N, Aftring, R, Viberti, G, Kahn, SE |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
by: Lachin, J, et al.
Published: (2011) -
Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.
by: Kahn, SE, et al.
Published: (2011) -
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
by: Kahn, SE, et al.
Published: (2006) -
Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain
by: Haffner, S, et al.
Published: (2007) -
ADOPT: The effectiveness of metformin versus glyburide in type 2 diabetes
by: Herman, W, et al.
Published: (2007)